Prime Therapeutics Reports Modest Drug Trend Increases

Prime Therapeutics LLC’s 2019 drug trend report showed single-digit increases for its commercial and Medicare Part D lines of business. Medicaid trend increased 10.2%, with utilization of specialty drugs remaining the largest driver of trend. In all lines of business, utilization of traditional drugs increased at a typical rate of 0.5% to 2.7%. Meanwhile, as brand drugs continued transitioning to generics in both government programs, the unit cost of specialty drugs went down.

© 2024 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong has been producing infographics and data stories on employer-sponsored insurance, public health insurance programs and prescription drug coverage for AIS Health’s Health Plan Weekly and Radar on Drug Benefits since 2018. She also manages AIS Health’s annual executive compensation database for top insurers and Blue Cross and Blue Shield affiliates. Before joining AIS Health, she interned at WBEZ, Al Jazeera English and The New York Times Chinese. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting.

Related Posts

iv-drip-bag
July 11

Report Details Providers’ Mounting Concerns With White Bagging

READ MORE
golden-gate-bridge
July 11

Most Payers Have Not Followed Blue Shield of California’s PBM Unbundling Model

READ MORE
pills
July 11

An Overview of Medicare Part D Enrollment, Costs in 2024

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today